1. Home
  2. LADR vs AVLN Comparison

LADR vs AVLN Comparison

Compare LADR & AVLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ladder Capital Corp

LADR

Ladder Capital Corp

HOLD

Current Price

$9.85

Market Cap

1.3B

Sector

Real Estate

ML Signal

HOLD

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$28.06

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LADR
AVLN
Founded
2008
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2013
2026

Fundamental Metrics

Financial Performance
Metric
LADR
AVLN
Price
$9.85
$28.06
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$12.25
N/A
AVG Volume (30 Days)
1.1M
520.1K
Earning Date
04-23-2026
N/A
Dividend Yield
8.98%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
N/A
N/A
Revenue This Year
$31.66
N/A
Revenue Next Year
$16.92
N/A
P/E Ratio
$485.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.61
$27.33
52 Week High
$11.92
$33.32

Technical Indicators

Market Signals
Indicator
LADR
AVLN
Relative Strength Index (RSI) 44.19 32.04
Support Level $9.61 $27.37
Resistance Level $10.44 $29.48
Average True Range (ATR) 0.18 2.48
MACD -0.04 -0.30
Stochastic Oscillator 25.53 14.40

Price Performance

Historical Comparison
LADR
AVLN

About LADR Ladder Capital Corp

Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments: Loans, which derive maximum revenue; Securities; and Real Estate.

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Share on Social Networks: